Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Proposed Rules 65887 

recommended weight, height, age, or 

developmental stage or combination 

thereof of the infant. 

(4) Warnings, statements, or graphic 

pictorials on the product and package 

shall not indicate or imply that the 

infant may be left in the product 

without an adult caregiver in 

attendance. 

§ 1242.7 Instructional literature 

(a) Instructions shall be provided with 

the product and shall be easy to read 

and understand and shall be in the 

English language at a minimum. These 

instructions shall include information 

on assembly, maintenance, cleaning, 

and use, where applicable. 

(b) The instructions shall include all 

warnings specified in § 1242.6(e). 

(c) The instructions shall address the 

following additional warnings: 

(1) Read all instructions before using 

this product. 

(2) Keep instructions for future use. 

(3) Do not use this this product if it 

is damaged or broken. 

(4) Instructions shall indicate the 

manufacturer’s recommended maximum 

weight, height, age, developmental 

level, or combination thereof, of the 

infant for whom the nursing pillow is 

intended. If this product is not intended 

for use by a child for a specific reason, 

the instructions shall so state this 

limitation. 

(d) The cautions and warnings in the 

instructions shall meet the requirements 

specified in § 1242.6(d)(4), 

§ 1242.6(d)(5), and § 1242.6(d)(6), except 

that sections 6.4 and 7.2 through 7.6.3 

of ANSI Z535.4—2011, American 

National Standard for Product Safety 

Signs and Labels, need not be applied. 

However, the signal word and safety 

alert symbol shall contrast with the 

background of the signal word panel, 

and the cautions and warnings shall 

contrast with the background of the 

instructional literature. 

Note 5 to paragraph (d)—For example, the 

signal word, safety alert symbol, and the 

warnings may be black letters on a white 

background, white letters on a black 

background, navy blue letters on an off-white 

background, or some other high-contrast 

combination. 

(e) Any instructions provided in 

addition to those required by this 

section shall not contradict or confuse 

the meaning of the required information 

or be otherwise misleading to the 

consumer. 

Note 6 to paragraph (e)—For additional 

guidance on the design of warnings for 

instructional literature, please refer to ANSI 

Z535.6, American National Standard: 

Product Safety Information in Product 

Manuals, Instructions, and Other Collateral 

Materials. 

§ 1242.8 Incorporation by Reference 

ANSI Z535.4–2011, American 

National Standard for Product Safety 

Signs and Labels, approved October 20, 

2017, is incorporated by reference. The 

Director of the Federal Register 

approves this incorporation by reference 

in accordance with 5 U.S.C. 552(a) and 

1 CFR part 51. This material is available 

for inspection at the U.S. Consumer 

Product Safety Commission and at the 

National Archives and Records 

Administration (NARA). Contact the 

U.S. Consumer Product Safety 

Commission at: the Office of the 

Secretary, U.S. Consumer Product 

Safety Commission, 4330 East West 

Highway, Bethesda, MD 20814, 

telephone (301) 504–7479, email: cpscos@cpsc.gov. For information on the 

availability of this material at NARA, 

email fr.inspection@nara.gov, or go to: 

www.archives.gov/federal-register/cfr/ 

ibr-locations.html. A free, read-only 

copy of the standard is available for 

viewing on the ANSI website at https:// 

ibr.ansi.org/Standards/nema.aspx. You 

may also obtain a copy from American 

National Standards Institute (ANSI), 25 

West 43rd Street, 4th Floor, New York, 

NY 10036, USA, telephone: (212) 642– 

4900, www.ansi.org. 

Alberta E. Mills, 

Secretary, Consumer Product Safety 

Commission. 

[FR Doc. 2023–20156 Filed 9–25–23; 8:45 am] 

BILLING CODE 6355–01–P 

DEPARTMENT OF THE TREASURY 

Internal Revenue Service 

26 CFR Part 52 

[REG–105954–22] 

RIN 1545–BQ40 

Superfund Chemical Taxes; Hearing 

AGENCY: Internal Revenue Service (IRS), 

Treasury. 

ACTION: Notice of proposed rulemaking; 

notice of hearing. 

SUMMARY: This document provides a 

notice of public hearing on proposed 

regulations relating to the excise taxes 

imposed on certain chemicals and 

certain imported substances. 

DATES: The public hearing on this 

proposed regulation has been scheduled 

for October 25, 2023, at 10 a.m. ET. The 

IRS must receive speakers’ outlines of 

the topics to be discussed at the public 

hearing by October 11, 2023. If no 

outlines are received by October 11, 

2023, the public hearing will be 

cancelled. 

ADDRESSES: The public hearing is being 

held in the Auditorium, at the Internal 

Revenue Service Building, 1111 

Constitution Avenue NW, Washington, 

DC. Due to security procedures, visitors 

must enter at the Constitution Avenue 

entrance. In addition, all visitors must 

present a valid photo identification to 

enter the building. Because of access 

restrictions, visitors will not be 

admitted beyond the immediate 

entrance area more than 30 minutes 

before the hearing starts. Participants 

may alternatively attend the public 

hearing by telephone. 

Send Submissions to CC:PA:1:PR 

(REG–105954–22), Room 5205, Internal 

Revenue Service, P.O. Box 7604, Ben 

Franklin Station, Washington, DC 

20044. Submissions may be hand 

delivered Monday through Friday to 

CC:PA:1:PR (REG–105954–22), Couriers 

Desk, Internal Revenue Service, 1111 

Constitution Avenue NW, Washington, 

DC 20224 or sent electronically via the 

Federal eRulemaking Portal at 

www.regulations.gov (IRS REG–105954– 

22) (preferred). 

FOR FURTHER INFORMATION CONTACT: 

Concerning the proposed regulations, 

Stephanie Bland or Natalie Payne, (202) 

317–6855; concerning submissions of 

comments, the hearing and/or to be 

placed on the building access list to 

attend the public hearing, call Vivian 

Hayes (202) 317–6901 (not a toll-free 

numbers) or by email to 

publichearings@irs.gov (preferred). 

SUPPLEMENTARY INFORMATION: The 

subject of the public hearing is the 

notice of proposed rulemaking (REG– 

105954–22) that was published in the 

Federal Register on Wednesday, March 

29, 2023, (FR 88 18446). 

The rules of 26 CFR 601.601(a)(3) 

apply to the hearing. Persons who wish 

to present oral comments at the hearing 

must submit an outline of the topics to 

be discussed and the time to be devoted 

to each topic by October 11, 2023. 

A period of 10 minutes will be 

allotted to each person for making 

comments. An agenda showing the 

scheduling of the speakers will be 

prepared after the deadline for receiving 

outlines has passed. Copies of the 

agenda will be available free of charge 

at the hearing, and via the Federal 

eRulemaking Portal 

(www.Regulations.gov) under the title of 

Supporting & Related Material. If no 

outline of the topics to be discussed at 

the hearing is received by October 11, 

2023, the public hearing will be 

cancelled. If the public hearing is 

cancelled, a notice of cancellation of the 

public hearing will be published in the 

Federal Register. 


lotter on DSK11XQN23PROD with PROPOSALS1
65888 Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Proposed Rules 

Individuals who want to testify in 

person at the public hearing must send 

an email to publichearings@irs.gov to 

have your name added to the building 

access list. The subject line of the email 

must contain the regulation number 

REG–105954–22 and the language 

TESTIFY In Person. For example, the 

subject line may say: Request to 

TESTIFY In Person at Hearing for REG– 

105954–22. 

Individuals who want to testify by 

telephone at the public hearing must 

send an email to publichearings@irs.gov 

to receive the telephone number and 

access code for the hearing. The subject 

line of the email must contain the 

regulation number REG–105954–22 and 

the language TESTIFY Telephonically. 

For example, the subject line may say: 

Request to TESTIFY Telephonically at 

Hearing for REG–105954–22. 

Individuals who want to attend the 

public hearing in person without 

testifying must also send an email to 

publichearings@irs.gov to have your 

name added to the building access list. 

The subject line of the email must 

contain the regulation number REG– 

105954–22 and the language ATTEND 

In Person. For example, the subject line 

may say: Request to ATTEND Hearing In 

Person for REG–105954–22. Requests to 

attend the public hearing must be 

received by 5 p.m. ET by October 20, 

2023. 

Individuals who want to attend the 

public hearing by telephone without 

testifying must also send an email to 

publichearings@irs.gov to receive the 

telephone number and access code for 

the hearing. The subject line of the 

email must contain the regulation 

number REG–105954–22 and the 

language ATTEND Hearing 

Telephonically. For example, the 

subject line may say: Request to 

ATTEND Hearing Telephonically for 

REG–105954–22. Requests to attend the 

public hearing must be received by 5 

p.m. ET by October 20, 2023. 

Hearings will be made accessible to 

people with disabilities. To request 

special assistance during a hearing 

please contact the Publications and 

Regulations Branch of the Office of 

Associate Chief Counsel (Procedure and 

Administration) by sending an email to 

publichearings@irs.gov (preferred) or by 

telephone at (202) 317–6901 (not a tollfree number) by October 20, 2023. Any 

questions regarding speaking at or 

attending a public hearing may also be 

emailed to publichearings@irs.gov. 

Oluwafunmilayo A. Taylor, 

Section Chief, Publications and Regulations 

Branch, Associate Chief Counsel, (Procedure 

and Administration). 

[FR Doc. 2023–20840 Filed 9–25–23; 8:45 am] 

BILLING CODE 4830–01–P 

DEPARTMENT OF THE TREASURY 

Internal Revenue Service 

26 CFR Part 54 

[REG 115762–23] 

RIN 1545–BQ94 

DEPARTMENT OF LABOR 

Employee Benefits Security 

Administration 

29 CFR Part 2590 

RIN 1210–AC24 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

45 CFR Part 149 

[CMS–9890–P] 

RIN 0938–AV39 

Federal Independent Dispute 

Resolution (IDR) Process 

Administrative Fee and Certified IDR 

Entity Fee Ranges 

AGENCY: Internal Revenue Service, 

Department of the Treasury; Employee 

Benefits Security Administration, 

Department of Labor; Centers for 

Medicare & Medicaid Services, 

Department of Health and Human 

Services. 

ACTION: Proposed rule. 

SUMMARY: This document sets forth 

proposed rules related to the fees 

established by the No Surprises Act for 

the Federal independent dispute 

resolution (IDR) process, as established 

by the Consolidated Appropriations Act, 

2021 (CAA). These proposed rules 

would amend existing regulations to 

provide that the administrative fee 

amount charged by the Department of 

the Treasury, the Department of Labor, 

and the Department of Health and 

Human Services (the Departments) to 

participate in the Federal IDR process, 

and the ranges for certified IDR entity 

fees for single and batched 

determinations will be set by the 

Departments through notice and 

comment rulemaking. These proposed 

rules would also set forth the 

methodology used to calculate the 

administrative fee and the 

considerations used to develop the 

certified IDR entity fee ranges. This 

document also proposes the amount of 

the administrative fee for disputes 

initiated on or after the later of the 

effective date of these rules or January 

1, 2024. Finally, this document 

proposes the certified IDR entity fee 

ranges for disputes initiated on or after 

the later of the effective date of these 

rules or January 1, 2024. In accordance 

with 5 U.S.C. 553(b)(4), a summary of 

this rule may be found at https://

www.regulations.gov/. 

DATES: To be assured consideration, 

comments must be received at one of 

the addresses provided below by 

October 26, 2023. 

ADDRESSES: Written comments may be 

submitted to the addresses specified 

below. Any comment that is submitted 

will be shared among the Departments. 

Please do not submit duplicates. 

Comments will be made available to 

the public. Warning: Do not include any 

personally identifiable information 

(such as name, address, or other contact 

information) or confidential business 

information that you do not want 

publicly disclosed. Comments are 

posted on the internet exactly as 

received and can be retrieved by most 

internet search engines. No deletions, 

modifications, or redactions will be 

made to the comments received, as they 

are public records. Comments may be 

submitted anonymously. 

In commenting, refer to file code 

CMS–9890–P. Because of staff and 

resource limitations, the Departments 

cannot accept comments by facsimile 

(FAX) transmission. 

Comments, including mass comment 

submissions, must be submitted in one 

of the following three ways (please 

choose only one of the ways listed): 

1. Electronically. You may submit 

electronic comments on this regulation 

to https://www.regulations.gov. Follow 

the ‘‘Submit a comment’’ instructions. 

2. By regular mail. You may mail 

written comments to the following 

address ONLY: Centers for Medicare & 

Medicaid Services, Department of 

Health and Human Services, Attention: 

CMS–9890–P, P.O. Box 8016, Baltimore, 

MD 21244–8016. 

Please allow sufficient time for mailed 

comments to be received before the 

close of the comment period. 

3. By express or overnight mail. You 

may send written comments to the 

following address ONLY: Centers for 


lotter on DSK11XQN23PROD with PROPOSALS1